Common pills taken by tens of millions of Americans may lower risk of liver cancer by a third, study finds

Researchers at the National Institutes of Health in Maryland found that those who took cholesterol-absorption inhibitors like ezetimibe had an up to 31 percent reduced risk of liver cancer compared to those who did not.